The new feature brings push health nudges and personalized health insights to smartphone users with chronic conditions.
New capabilities include women cycle tracking, Noise app, Activity Trends and App Store right on the wrist; also, there are new watch faces.
While wrist-worn wearables accounted for the majority of the market with 63.2% share, ear-worn devices experienced the fastest growth (135.1% YoY).
The market is expected to reach 279 million units by the end of 2023 with a compound annual growth rate (CAGR) of 8.9%.
Much of the growth was attributed to the growing number of ear-worn devices as they captured almost a quarter of the market during the year.
New devices include Fitbit Versa Lite Edition smartwatch, and a trio of activity trackers - Fitbit Inspire HR, Fitbit Inspire and child-friendly Fitbit Ace 2.
The story ends on May 31 when web-connected services won't work any more; Band owners will still be able to track their fitness activities, though.
The OnePulse smartwatch is described as a valuable tool for the medical provider to monitor chronically ill and elderly patients who plan to age in place.
Both the Galaxy Watch Active and Galaxy Fit have can automatically detect when the user begins certain common workouts like running or biking.
The Verisense platform provides complete clinical trial sponsor support, requiring a five-minute setup to initiate data collection and participant follow up.